Wed, March 11, 2020

Difei Yang Reiterated (AKBA) at Strong Buy with Decreased Target to $15 on, Mar 11th, 2020

Difei Yang of Mizuho, Reiterated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $16 to $15 on, Mar 11th, 2020.

Difei has made no other calls on AKBA in the last 4 months.



There are 2 other peers that have a rating on AKBA. Out of the 2 peers that are also analyzing AKBA, 0 agree with Difei's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Difei


  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $13 on, Thursday, February 20th, 2020
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $16 on, Monday, November 18th, 2019